Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Asset Purchase Agreement	High Trail	Common Stock	Common Stock Asset Purchase Agreement	Common Stock High Trail	Additional Paid-in Capital	Additional Paid-in Capital Asset Purchase Agreement	Additional Paid-in Capital High Trail	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning balance at Dec. 31, 2020	$ 23,382			$ 3			$ 216,305			$ (192,935)	$ 9
Beginning balance, shares at Dec. 31, 2020				27,074,791
Net loss	(236,024)									(236,024)
Issuance of restricted common stock, shares				2,025,597
Forfeiture of restricted common stock, shares				(647,659)
Reclassification of warrants to equity	97,088						97,088
Issuance of common stock upon exercise of stock option grants	9,033						9,033
Issuance of common stock upon exercise of stock option grants, shares				1,011,422
Issuance of common stock related to exercise of warrants	40,318						40,318
Issuance of common stock related to exercise of warrants, shares				6,405,605
Issuance of common stock in connection with acquisition of Healing Solutions assets	47,369						47,369
Issuance of common stock in connection with acquisition of Healing Solutions assets, shares				2,796,001
Issuance of restricted stock awards	7,669						7,669
Issuance of restricted stock awards, shares				769,104
Issuance of warrants to High Trail	39,016						39,016
Issuance of warrants to Midcap	589						589
Reclassification of warrants to liability	(21,260)						(21,260)
Warrant modification on extinguishment	17,399						17,399
Issuance of common stock	36,735	$ 11,075	$ 129,620			$ 2	36,735	$ 11,075	$ 129,618
Issuance of common stock, shares				2,666,667	704,548	12,284,161
Stock-based compensation	22,696						22,696
Other comprehensive income (loss)	(477)										(477)
Ending balance at Dec. 31, 2021	224,228			$ 5			653,650			(428,959)	(468)
Ending balance, shares at Dec. 31, 2021				55,090,237
Net loss	(196,292)									(196,292)
Issuance of restricted common stock	1			$ 1
Issuance of restricted common stock, shares				4,428,662
Forfeiture of restricted common stock, shares				(423,482)
Exercise of Prefunded Warrants, shares				3,013,850
Exercise of Prefunded Warrants	15,039						15,039
Issuance of common stock for settlement of seller note, shares				292,887
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt	767						767
Reclassification of warrants to equity	18,982						(18,982)
Issuance of common stock	46,834			$ 2			46,832
Issuance of common stock, shares				18,277,948
Issuance of common stock, shares				72,188
Issuance of common stock	43						43
Loss on initial issuance of equity	18,669						18,669
Issuance of warrant to contractors	1,137						1,137
Stock-based compensation	11,184						11,184
Other comprehensive income (loss)	(676)										(676)
Ending balance at Dec. 31, 2022	$ 101,952			$ 8			$ 728,339			$ (625,251)	$ (1,144)
Ending balance, shares at Dec. 31, 2022				80,752,290